← Evidence map

ArticleGut2016

Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein.

Giuseppe A Sautto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

52 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25661083